Literature DB >> 15748631

Metabolite-cytochrome P450 complex formation by methylenedioxyphenyl lignans of Piper cubeba: mechanism-based inhibition.

Tepy Usia1, Tadashi Watabe, Shigetoshi Kadota, Yasuhiro Tezuka.   

Abstract

Five methylenedioxyphenyl lignans, (-)-clusin (1), (-)-dihydroclusin (2), (-)-yatein (3), (-)-hinokinin (4), and (-)-dihydrocubebin (5), were isolated from Piper cubeba as potent and selective inhibitors against cytochrome P450 3A4 (CYP3A4). In this study, we investigated the mechanism of inhibition of CYP3A4 by these lignans and the possibility of their mechanism-based inhibition. Using [N-methyl-14C]erythromycin as a substrate, all lignans appear to be showed mixed-type of inhibition with apparent Ki of 1.96-4.07 microM. Furthermore, all lignans (1-5) inhibited CYP3A4 in a time-, concentration-, and NADPH-dependent manners and thus appear to be the mechanism-based inhibitors of CYP3A4. The apparent inactivation parameter, K(I) for these compounds were in the range of 0.054-0.373 microM, whereas the k(inact) values were 0.225-0.320 min-1. Among them, (-)-clusin (1) and (-)-dihydroclusin (2) were found to be the most potent CYP3A4 inactivator with apparent K(I) and k(inact) values of 0.082, 0.054 microM and 0.253, 0.310 min-1, respectively. Spectral scanning of microsomes with these lignans yielded an absorbance at 455 nm, suggesting that all of them appear to inactivate the cytochrome P450 via the formation of a metabolite intermediate complex. This pattern is consistent with the metabolism of the methylenedioxyphenyl compounds. These results indicate that (-)-clusin (1), (-)-dihydroclusin (2), (-)-yatein (3), (-)-hinokinin (4), and (-)-dihydrocubebin (5) are effective mechanism-based inhibitors of CYP3A4.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15748631     DOI: 10.1016/j.lfs.2004.12.005

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Irreversible Enzyme Inhibition Kinetics and Drug-Drug Interactions.

Authors:  Michael Mohutsky; Stephen D Hall
Journal:  Methods Mol Biol       Date:  2021

2.  In vivo infection by Trypanosoma cruzi: a morphometric study of tissue changes in mice.

Authors:  Viviane Rodrigues Esperandim; Daniele da Silva Ferreira; Karen Cristina Sousa Rezende; Wilson Roberto Cunha; Juliana Saraiva; Jairo Kenupp Bastos; Márcio Luis Andrade E Silva; Sérgio de Albuquerque
Journal:  Parasitol Res       Date:  2012-07-27       Impact factor: 2.289

3.  Mechanism-Based Inhibition of CYP3A4 by Podophyllotoxin: Aging of an Intermediate Is Important for in Vitro/in Vivo Correlations.

Authors:  Carlo Barnaba; Jaydeep Yadav; Swati Nagar; Ken Korzekwa; Jeffrey P Jones
Journal:  Mol Pharm       Date:  2016-07-01       Impact factor: 4.939

4.  Influence of sesamin on CYP2C-mediated diclofenac metabolism: in vitro and in vivo analysis.

Authors:  Kaori Yasuda; Sera Ueno; Erika Ueda; Miyu Nishikawa; Kie Takeda; Masaki Kamakura; Shinichi Ikushiro; Toshiyuki Sakaki
Journal:  Pharmacol Res Perspect       Date:  2015-08-25

5.  Quantitative estimation of (-)-hinokinin, a trypanosomicidal marker in Piper cubeba, and some of its commercial formulations using HPLC-PDA.

Authors:  Kothapalli Haribabu; Makula Ajitha; Uppuluri Venkata Mallavadhani
Journal:  J Pharm Anal       Date:  2014-03-29

Review 6.  An Ethnopharmacological, Phytochemical and Pharmacological Review on Lignans from Mexican Bursera spp.

Authors:  Maria Carla Marcotullio; Massimo Curini; Judith X Becerra
Journal:  Molecules       Date:  2018-08-08       Impact factor: 4.411

7.  Inhibition of baicalin on metabolism of phenacetin, a probe of CYP1A2, in human liver microsomes and in rats.

Authors:  Na Gao; Bing Qi; Fang-jun Liu; Yan Fang; Jun Zhou; Lin-jing Jia; Hai-ling Qiao
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.